PHF6, H2BC20P and JMJD6 epigenetic regulators were selected from those 200 genes that showed the greatest difference in expression levels in the case of comparing ibrutinib-treated and untreated DLBCL cells. The gene discussed is PHF6; the disease is diffuse large B-cell lymphoma.